Close Menu

Helix

Several groups are developing diagnostic viral genome sequencing assays and panels, which promise high sensitivity and additional information on viral origin and spread.

Assays like SwabSeq, Dx-Seq, and LAMP-Seq promise to analyze tens to hundreds of thousands of samples in parallel but might be constrained by sample availability.

Some of the market's most influential voices, including Kári Stefánsson and Linda Avey, believe that consumer genomics is not on the way out but rather experiencing a period of transition.

The team identified 64 statistically significant gene-based associations with phenotypes, illustrating the value of large, deeply phenotyped cohorts.

The company hopes to help consumer genomics firms and healthcare companies reduce the IT burdens associated with launching a new test.

The Tapestry study will initially return genetic results for familial hypercholesterolemia, hereditary breast and ovarian cancer, and Lynch syndrome to patients.

AdventHealth in Orlando is offering its members free DNA testing, the Associated Press reports, noting that it also plans to use the data collected in research.

New Privacy Coalition

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

NatGeo will continue to conduct research using its database, which includes data on roughly a million individuals.

Several genetic test providers thought Helix would give them a national sales channel for their genomics apps, but this didn't materialize.

Pages

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.